|Articles|January 1, 2017
January 2017: Setting the Pace for the Patient Journey
Author(s)Triplefin
How Triplefin’s suite of hub-based e-solutions and customized investments in the “human touch” are outrunning the clock on prior authorization claims-a key source of delays in patient speed to therapy.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Preview: Roche’s Refresh
2
FDA Approves Novo Nordisk’s Wegovy Pill for Weight Management
3
Pharmaceutical Executive Daily: Nine New Additions to TrumpRx
4
Data Quality in Drug Development: The Missing Foundation to Realize AI’s Promise in Clinical Trials
5